Welcome to Epidy's COVID-19 Risk Factors platform

Study characteristics

Country where the study was conducted

Study type

Review

Data Source

Size of study popopulation

3 studies enrolling

Study population description

MEDLINE, EMBASE and Global Health, from 1st January 2019 to 5th March 2020

Study population characteristics

Systematic review and meta-analysis of predictive symptoms and comorbidities for severe COVID-19 infection

Follow up type

Follow up

Results

Outcome related to coronavirus

COVID-19 (severe/critical)

Number of cases

Case definition

Associated factor category

Comorbidities

Associated factor name

Hypertension

Associated factor description

Risk reference category

Not present

Number of cases in the reference category

Total number of patients in the reference category

Risk comparison category

Present

Number of cases in the comparison category

Total number of patients in the comparison category

Type of measure of association

Odds ratio

Risk value (95% confidence interval)

1.970 (1.400-2.770)

Significant preventive factor

Yes

Significant risk factor

Yes

Is the risk adjusted?

Risk adjustment description

Other information

Comment

Article Quality

QC done?

Go Back

View Risk

Please log in for more details.

Create your Epidy Account. It's FREE.